Richard J. Wanstall
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Richard J. Wanstall
Earlier roles on record: CFO at Rein Therapeutics, Inc. (RNTX) until May 6, 2022. The proxy statement of Rein Therapeutics, Inc. reports total compensation of $1,197,030 for Richard J. Wanstall in fiscal 2021, including a base salary of $402,270. Disclosed compensation is on record for 3 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2022-05-06
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Rein Therapeutics, Inc. (RNTX) | Chief Financial Officer and Treasurer | $402,270 | $1,197,030 |
| 2020 | Rein Therapeutics, Inc. (RNTX) | Chief Financial Officer and Treasurer | $330,000 | $715,098 |
| 2019 | Rein Therapeutics, Inc. (RNTX) | Chief Financial Officer and Treasurer | $292,000 | $401,442 |
Recent activity
No call appearances or filed executive changes recorded yet.